Larry B. Goldstein, M.D., professor and chair of the Department of Neurology at UK HealthCare, delivered a compelling presentation on stroke prevention that underscores the critical role of primary care providers in reducing stroke incidence. Stroke is the fourth leading cause of death in the United States, with about 795,000 new and recurrent strokes occurring…
Nearly all individualswith dementia will experience behavioral or psychological symptoms during their disease course, presenting significant challenges for caregivers and clinicians alike. Understanding how to identify, evaluate and manage these symptoms while minimizing medication use remains essential for improving patient outcomes and quality of life. In a recent “MedChat” podcast, Rachel N. Hart, D.O., geriatric…
After caring for hearts in Louisville for more than three decades, Joseph A. Lash, M.D., is preparing to close a remarkable chapter in medicine. As executive medical director of Norton Heart & Vascular Institute and Rounsavall Family Foundation endowed chair, Dr. Lash witnessed and contributed to transformations in cardiovascular care that have fundamentally changed what…
New technology is bringing life-changing esophageal cancer treatment to patients at Norton Audubon Hospital. William B. Evans III, M.D., gastroenterologist with Norton Gastroenterology Consultants of Louisville, is the first and only physician in Louisville to offer truFreeze spray cryotherapy for patients with esophageal cancer. “I’m proud to be the first in the city to provide…
When patients present with cardiac symptoms, choosing the right cardiac diagnostic test depends on risk stratification, symptom frequency and clinical context. Here is a practical guide to navigating cardiology testing in primary care, adapted from a continuing medical education presentation by Mostafa O. El-Refai, M.D., interventional cardiologist with Norton Heart & Vascular Institute. Chest pain:…
Cardiometabolic care is undergoing a transformation that includes the rise of prescribing GLP-1 receptor agonists as multisystem therapeutics. “Treating diabetes, cardiovascular disease and renal or hepatic dysfunction as isolated conditions is now an outdated approach in cardiometabolic care,” said Catrina R. Hancock, PA-C, physician assistant with Norton Heart & Vascular Institute. “Instead, treatment has shifted…
This continuing medical education presentation features Norton Heart & Vascular Institute electrophysiologist Megan E. Gruber, D.O., discussing critical updates in atrial fibrillation (A-fib) treatment based on the latest guideline revisions. Dr. Gruber provides clinicians with practical insights into the evolving approach to A-fib management, including refined classification systems that mirror heart failure staging, enhanced focus…
Dementia care is experiencing a revolutionary shift. For decades, physicians had little to offer patients beyond symptomatic treatments and supportive care. Today, the medical community stands at the edge of a new era — one defined by precise biomarker testing and disease-modifying therapies that represent genuine new treatments for Alzheimer’s disease. Understanding the new treatment…
A groundbreaking clinical trial at Norton Cancer Institute is exploring whether CAR T-cell therapy —a cellular therapy originally developed to treat cancer — could provide a curative treatment for patients with severe autoimmune diseases, including systemic lupus erythematosus (SLE), myositis and scleroderma. The RESOLUTION trial, led by principal investigator Don A. Stevens, M.D., hematologist/oncologist with…